Vertebral Technologies Inc - Product Pipeline Analysis, 2017 Update

GlobalData
28 Pages - GLDATA62907
$750.00

Summary

Vertebral Technologies Inc (VTI) is a medical equipment company that manufactures and develops implantable spinal devices. The company's products include interfuse, interlink and intergraft. It offers proven solution for implanting footprint devices. VTI's intergraft include Matrix O and bone matrix in various forms for strips, blocks, crunch, and putty. The company's bone forming offers chondrocytes, osteocytes, bone marrow cells, cartilage, and new bone. Its intergraft products include matrix 0i strip, dbm putty, matrix oi, dbm crunch, matrix filler and dbm. VTI also offers intercushion motion preservation device. The company's implantable device is customized through proprietary intra-operative assembly technology. VTI is headquartered in Minneapolis, Minnesota, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Vertebral Technologies Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Vertebral Technologies Inc Company Overview 4
Vertebral Technologies Inc Company Snapshot 4
Vertebral Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Vertebral Technologies Inc – Pipeline Analysis Overview 6
Vertebral Technologies Inc - Key Facts 6
Vertebral Technologies Inc - Major Products and Services 7
Vertebral Technologies Inc Pipeline Products by Development Stage 8
Vertebral Technologies Inc Ongoing Clinical Trials by Trial Status 10
Vertebral Technologies Inc Pipeline Products Overview 12
InterCushion Disc Nucleus Replacement System 12
InterCushion Disc Nucleus Replacement System Product Overview 12
InterCushion Disc Nucleus Replacement System Clinical Trial 13
InterFuse DA Intervertebral Body Fusion Device 14
InterFuse DA Intervertebral Body Fusion Device Product Overview 14
InterFuse Intervertebral Body Fusion Device 15
InterFuse Intervertebral Body Fusion Device Product Overview 15
InterFuse L - Intervertebral Body Fusion Device 16
InterFuse L - Intervertebral Body Fusion Device Product Overview 16
InterFuse S Intervertebral Body Fusion Device 17
InterFuse S Intervertebral Body Fusion Device Product Overview 17
InterFuse S Intervertebral Body Fusion Device Clinical Trial 18
InterFuse T - Intervertebral Body Fusion Device 19
InterFuse T - Intervertebral Body Fusion Device Product Overview 19
InterFuse T - Intervertebral Body Fusion Device Clinical Trial 20
Vertebral Technologies Inc - Key Competitors 21
Vertebral Technologies Inc - Key Employees 22
Vertebral Technologies Inc - Locations And Subsidiaries 23
Head Office 23
Recent Developments 24
Vertebral Technologies Inc, Recent Developments 24
May 01, 2012: Vertebral Technologies Implants Over 2,000 InterFuse Interbody Fusion Devices In US 24
Jan 06, 2010: VIT Implants Its InterFuse Interbody Fusion Device Using Intraoperative Assembly Technology In 500th Patient 24
Appendix 25
Methodology 25
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Vertebral Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Vertebral Technologies Inc Pipeline Products by Equipment Type 5
Vertebral Technologies Inc Pipeline Products by Indication 5
Vertebral Technologies Inc Ongoing Clinical Trials by Trial Status 5
Vertebral Technologies Inc, Key Facts 6
Vertebral Technologies Inc, Major Products and Services 7
Vertebral Technologies Inc Number of Pipeline Products by Development Stage 8
Vertebral Technologies Inc Pipeline Products Summary by Development Stage 9
Vertebral Technologies Inc Ongoing Clinical Trials by Trial Status 10
Vertebral Technologies Inc Ongoing Clinical Trials Summary 11
InterCushion Disc Nucleus Replacement System - Product Status 12
InterCushion Disc Nucleus Replacement System - Product Description 12
InterCushion Disc Nucleus Replacement System - A Pilot Clinical Study to Assess the Safety and Effectiveness of the InterCushion Disc Nucleus Prosthesis in Patients Receiving Discectomy 13
InterFuse DA Intervertebral Body Fusion Device - Product Status 14
InterFuse DA Intervertebral Body Fusion Device - Product Description 14
InterFuse Intervertebral Body Fusion Device - Product Status 15
InterFuse Intervertebral Body Fusion Device - Product Description 15
InterFuse L - Intervertebral Body Fusion Device - Product Status 16
InterFuse L - Intervertebral Body Fusion Device - Product Description 16
InterFuse S Intervertebral Body Fusion Device - Product Status 17
InterFuse S Intervertebral Body Fusion Device - Product Description 17
InterFuse S Intervertebral Body Fusion Device - A Multi-Center Prospective Study of Vertebral Technologies, Inc. (VTI) InterFuse S and InterFuse T for the Treatment of Scoliosis, Spondylolisthesis and Degenerative Disc Disease 18
InterFuse T - Intervertebral Body Fusion Device - Product Status 19
InterFuse T - Intervertebral Body Fusion Device - Product Description 19
InterFuse T - Intervertebral Body Fusion Device - A Multi-Center Prospective Study of Vertebral Technologies, Inc. (VTI) InterFuse S and InterFuse T for the Treatment of Scoliosis, Spondylolisthesis and Degenerative Disc Disease 20
InterFuse T - Intervertebral Body Fusion Device - A Prospective Study of the InterFuse T 20
Vertebral Technologies Inc, Key Employees 22
Glossary 26

List of Figures
Vertebral Technologies Inc Pipeline Products by Equipment Type 5
Vertebral Technologies Inc Pipeline Products by Development Stage 8
Vertebral Technologies Inc Ongoing Clinical Trials by Trial Status 10

$750.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838